In the ever-evolving world of gut health, the prominence of Lactobacillus reuteri has surged, making it a subject of interest for both researchers and health-conscious individuals. Known for its probiotic prowess, this beneficial bacterium occupies a crucial role in maintaining the gastrointestinal tract’s health, enhancing immune response, and guarding against harmful pathogens. The study of Lactobacillus reuteri not only sheds light on its therapeutic potential for various digestive disorders but also highlights its impact on overall well-being, underpinning the profound connection between gut microbiota and health.
This article will delve into the essence of Lactobacillus reuteri, tracing its historical background and discovery to underscore its importance in the realm of microbiology and probiotics. By exploring the multitude of benefits Lactobacillus reuteri offers for digestive health, alongside its contribution to bolstering the immune system and reducing inflammation, readers will gain a comprehensive understanding of its healing capabilities. Furthermore, discussions on its role in combating gastrointestinal disorders, potential side effects, and the incorporation of Lactobacillus reuteri into daily diet and supplements will equip readers with the knowledge to leverage this reuteri probiotic for optimising gut health and beyond.
What is Lactobacillus Reuteri?
Lactobacillus reuteri (L. reuteri) is a well-studied probiotic bacterium that can colonize a large number of mammals. In humans, L. reuteri is found in different body sites, including the gastrointestinal tract, urinary tract, skin, and breast milk . The abundance of L. reuteri varies among different individuals.
L. reuteri is a heterofermentative species that grows in oxygen-limited atmospheres and colonizes the gastrointestinal tract of humans and animals . It can withstand a wide variety of pH environments, employs multiple mechanisms that allow it to successfully inhibit pathogenic microorganisms, and has been shown to secrete antimicrobial intermediaries .
L. reuteri has been demonstrated to be one of the truly indigenous bacteria of the human gastrointestinal tract . It naturally colonizes a wide range of vertebrates, including pigs, rodents, and chickens, and has gone through long-term evolution to diversify into host-adapted lineages . This organism is most typically found in the proximal digestive tract of the host .
Several studies have assessed the safety of L. reuteri in adults, children, infants, and even in an HIV-infected population . Doses as high as 2.9 × 10^9^ colony-forming units (cfu)/day were found to be well tolerated, safe, and efficacious in humans .
Historical Background and Discovery
Lactobacillus reuteri was first isolated in 1962 by German microbiologist Gerhard Reuter, after whom the species is named. Reuter discovered L. reuteri in human fecal and intestinal samples while studying lactic acid bacteria at the University of Göteborg in Sweden .
Since its discovery, L. reuteri has been found to naturally colonize the gastrointestinal tract of a wide range of vertebrates, including humans, pigs, rodents, and chickens. This probiotic bacterium has undergone long-term evolution, diversifying into host-adapted lineages .
Numerous studies have assessed the safety and efficacy of L. reuteri in various populations, including adults, children, infants, and even HIV-infected individuals. Doses as high as 2.9 × 10^9^ colony-forming units (cfu) per day were found to be well tolerated, safe, and effective in human subjects .
Research has revealed that L. reuteri is one of the truly indigenous bacteria of the human gastrointestinal tract, typically found in the proximal digestive tract of the host . Its ability to withstand a wide range of pH environments and employ multiple mechanisms to inhibit pathogenic microorganisms has made it a subject of great interest in the field of probiotics and gut health.
The discovery of L. reuteri and subsequent research into its prevalence, effects, and potential applications have paved the way for a deeper understanding of this probiotic powerhouse. As scientists continue to unravel the complexities of the gut microbiome and its impact on overall health, L. reuteri remains at the forefront of probiotic research and development.
Benefits of Lactobacillus Reuteri for Digestive Health
Lactobacillus reuteri has shown promising potential in supporting digestive health through various mechanisms. Studies have demonstrated that L. reuteri can help alleviate symptoms of common gastrointestinal disorders such as infantile colic, diarrhea, and constipation .
In infants with colic, supplementation with L. reuteri DSM 17938 for 21 to 30 days significantly decreased daily crying and fussing times, and reduced the duration of crying episodes . This effect was observed in breastfed infants, while the efficacy in formula-fed infants remains controversial .
L. reuteri has also been found to slightly reduce the duration of diarrhea in children . In cases of acute gastroenteritis or infectious diarrhea, L. reuteri DSM 17938 supplementation could shorten a child’s hospital stay .
For individuals suffering from constipation, taking L. reuteri by mouth has been shown to reduce constipation severity . Single-drug administration of L. reuteri DSM 17938 significantly improved defecation frequency, painful defecation, and reduced fecal mass in the rectum in both children and adults .
In the management of Helicobacter pylori infection, a common cause of gastric ulcers, L. reuteri supplementation alongside standard drug therapies can help reduce side effects associated with the medications . While L. reuteri may not directly increase H. pylori eradication rates, it can alleviate abdominal pain, distension, and other treatment-related adverse events, thus improving patient compliance .
The beneficial effects of L. reuteri on digestive health can be attributed to its ability to modulate the gut microbiota, enhance the intestinal barrier function, and exert anti-inflammatory and immunomodulatory properties . By promoting a balanced gut microbiome and supporting the integrity of the intestinal lining, L. reuteri helps maintain a healthy digestive system and alleviates symptoms associated with various gastrointestinal disorders.
Lactobacillus Reuteri and Immune System Support
Lactobacillus reuteri has demonstrated promising potential in supporting the immune system through various mechanisms. Studies have shown that L. reuteri can stimulate the production of Foxp3+ regulatory T (Treg) cells, which play a crucial role in maintaining immune tolerance . Specifically, L. reuteri strains 17938 and Fn041 were found to induce the generation of Foxp3+ Treg cells in the intestinal mucosa .
In addition to promoting Treg cell production, L. reuteri has been shown to modulate the function of dendritic cells (DCs). L. reuteri ATTC PTA 6475 and its secreted factors induced the expression of maturation markers CD83 and CD86 on the surface of immature DCs, promoting their differentiation into anti-inflammatory phenotypes that secrete interleukin-10 (IL-10) . This DC-induced production of Foxp3+ Treg cells is essential for maintaining intestinal immune homeostasis .
L. reuteri also influences the activity of innate lymphoid cells (ILCs), particularly group 3 ILCs (ILC3s). While L. reuteri ATCC PTA 6475 reduced the number of ILC3s, potentially limiting tissue damage , L. reuteri CF48-3A promoted ILC3 production and induced the differentiation of IgA+ B cells, leading to the generation of IgA . However, the protective or autoimmune role of this IgA remains unclear.
Furthermore, L. reuteri has been found to enhance the phagocytotic ability of macrophages by increasing their production of nitric oxide (NO) . Simultaneously, L. reuteri regulated NO levels to inhibit inflammation induced by bacterial infection .
The immunomodulatory effects of L. reuteri are mediated, in part, through Toll-like receptor 2 (TLR2) signaling. L. reuteri 17938, upon recognition by TLR2, led to an increase in Foxp3+ Treg cells and a decrease in CD4+CD44+ effector T cells . TLR2 activation also induced the generation and activation of CD103+ DCs, characterized by the expression of co-stimulatory markers CD80 and CD86 . Moreover, TLR2 signaling mediated the decrease in proinflammatory cytokines IL-1β and interferon-γ (IFN-γ) in mice .
In terms of antibody production, L. reuteri FN041 increased the synthesis of secretory IgA (sIgA) in the ileum of mice , while L. reuteri CRL1324 stimulated both IgA and IgG production, which are related to anti-infection functions .
Lastly, L. reuteri has been shown to regulate cytokine production to improve intestinal mucosal barrier structure and permeability. It inhibited the production of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α), IL-1β, IL-6, and IL-8 , while promoting the production of the anti-inflammatory cytokine IL-10 . This cytokine modulation stabilizes the expression of tight junctions and E-cadherin, reinforcing the intestinal barrier function.
In conclusion, L. reuteri exhibits a multifaceted approach to immune system support, influencing the activity of various immune cells, modulating cytokine production, and enhancing intestinal barrier function. These immunomodulatory properties highlight the potential of L. reuteri as a probiotic for maintaining immune homeostasis and protecting against inflammatory conditions.
Role of Lactobacillus Reuteri in Reducing Inflammation
Lactobacillus reuteri plays a vital role in reducing inflammation in the gastrointestinal tract through various mechanisms. Studies have shown that L. reuteri strains can suppress the production of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6, and IL-8 . Additionally, L. reuteri promotes the production of the anti-inflammatory cytokine IL-10 .
One of the key mechanisms by which L. reuteri exerts its anti-inflammatory effects is through the activation of the aryl hydrocarbon receptor (AhR) . AhR is a ligand-activated transcription factor that plays a crucial role in maintaining intestinal homeostasis and regulating immune responses. L. reuteri strains produce indole-3-aldehyde, an AhR ligand, which activates the AhR pathway and promotes the differentiation of regulatory T cells (Tregs) . Tregs are essential for maintaining immune tolerance and suppressing excessive inflammation in the gut.
Furthermore, L. reuteri has been shown to modulate the expression of tight junction proteins, such as zonula occludens-1 (ZO-1) and E-cadherin, thereby strengthening the intestinal barrier function . A robust intestinal barrier prevents the translocation of harmful bacteria and their products, which can trigger inflammatory responses.
L. reuteri also interacts with the gut microbiota, promoting the growth of beneficial bacteria while inhibiting the growth of pathogenic species. This modulation of the gut microbiota composition contributes to the reduction of inflammation and the maintenance of a healthy intestinal environment .
In animal models of inflammatory bowel disease (IBD), such as dextran sulfate sodium (DSS)-induced colitis, administration of L. reuteri has been shown to alleviate intestinal inflammation, reduce the severity of colitis, and improve overall gut health . These findings highlight the potential therapeutic applications of L. reuteri in managing IBD and other inflammatory conditions of the gastrointestinal tract.
In conclusion, Lactobacillus reuteri plays a significant role in reducing inflammation in the gastrointestinal tract through multiple mechanisms, including the suppression of pro-inflammatory cytokines, activation of the AhR pathway, modulation of tight junction proteins, and interaction with the gut microbiota. These anti-inflammatory properties make L. reuteri a promising probiotic for the management of inflammatory bowel diseases and the maintenance of overall gut health.
Use in Treating Gastrointestinal Disorders
L. reuteri has shown promising potential in treating various gastrointestinal disorders. Studies have demonstrated that L. reuteri can help alleviate symptoms of common conditions such as infantile colic, diarrhea, constipation, functional abdominal pain, Helicobacter pylori infection, and inflammatory bowel disease .
In infants with colic, supplementation with L. reuteri DSM 17938 for 21 to 30 days significantly decreased daily crying and fussing times, and reduced the duration of crying episodes . This effect was observed in breastfed infants, while the efficacy in formula-fed infants remains controversial .
L. reuteri has also been found to slightly reduce the duration of diarrhea in children . In cases of acute gastroenteritis or infectious diarrhea, L. reuteri DSM 17938 supplementation could shorten a child’s hospital stay .
For individuals suffering from constipation, taking L. reuteri by mouth has been shown to reduce constipation severity . Single-drug administration of L. reuteri DSM 17938 significantly improved defecation frequency, painful defecation, and reduced fecal mass in the rectum in both children and adults .
In the management of Helicobacter pylori infection, a common cause of gastric ulcers, L. reuteri supplementation alongside standard drug therapies can help reduce side effects associated with the medications . While L. reuteri may not directly increase H. pylori eradication rates, it can alleviate abdominal pain, distension, and other treatment-related adverse events, thus improving patient compliance .
The beneficial effects of L. reuteri on digestive health can be attributed to its ability to modulate the gut microbiota, enhance the intestinal barrier function, and exert anti-inflammatory and immunomodulatory properties . By promoting a balanced gut microbiome and supporting the integrity of the intestinal lining, L. reuteri helps maintain a healthy digestive system and alleviates symptoms associated with various gastrointestinal disorders.
Potential Side Effects and Safety Concerns
Lactobacillus reuteri is generally considered safe and well-tolerated when taken orally. It has been used safely alone and in combination with other probiotics for up to 6 months . However, some individuals may experience mild side effects such as diarrhea or constipation .
Special Precautions and Warnings
L. reuteri is possibly safe when taken by mouth appropriately during pregnancy and breast-feeding . It is also likely safe for most children when taken orally, having been used safely for up to 4 weeks in infants and up to 12 weeks in older children . However, there is insufficient reliable information to determine if L. reuteri is safe for very small premature infants .
Individuals with weakened immune systems should exercise caution when taking L. reuteri, as it has caused blood infections in a small number of people with compromised immunity . Those with damaged heart valves should also stop taking probiotics before dental or surgical procedures, as L. reuteri can cause an infection in the inner lining of the heart chambers and heart valve, although this is extremely rare .
Interactions
L. reuteri may interact with antibiotic drugs . As a type of friendly bacteria, L. reuteri can be affected by antibiotics, which are used to reduce harmful bacteria in the body . Taking antibiotics along with L. reuteri can reduce the effectiveness of the probiotic . To avoid this interaction, it is recommended to take L. reuteri products at least 2 hours before or after taking antibiotics .
Lactobacillus Reuteri in Daily Diet and Supplements
Lactobacillus reuteri can be found naturally in several foods, including dairy products like yogurt and cheese. Reuteri-rich yogurt is made with different strains of bacteria compared to conventional yogurt, resulting in a higher probiotic count and enhanced health benefits, especially for gut health .
In addition to dietary sources, L. reuteri can be increased in the gut by consuming prebiotic foods. Prebiotics are naturally high in fiber and include foods like bananas, garlic, and onions. These foods encourage the growth of beneficial bacteria in the gut, helping to maintain a healthy balance and support digestive health .
Supplementation is another effective way to increase L. reuteri levels in the body. Probiotic supplements containing L. reuteri strains, such as DSM 17938, have been shown to be safe and well-tolerated in various populations, including adults, children, and infants .
When choosing a probiotic supplement, it is essential to look for formulas that contain well-studied strains of L. reuteri. Some popular options include :
- Nutribliss Women’s Care Probiotic Capsules (25-90 Billion CFU)
- Nutribliss Men’s Care Probiotic Capsules (50 Billion CFU)
- Nutribliss Women’s Care Probiotic Go-Pack (15 Billion CFU)
- Nutribliss Vaginal & Urinary Complete Probiotic Capsules
These supplements are designed to support digestive health, immune function, and urinary and vaginal health in men and women .
It is important to note that while L. reuteri is generally considered safe, individuals with weakened immune systems or damaged heart valves should exercise caution when taking probiotics. Additionally, probiotics may interact with certain medications, such as antibiotics, so it is always best to consult with a healthcare professional before starting a new supplement regimen .
Conclusion
Throughout the exploration of Lactobacillus reuteri’s remarkable benefits, we have uncovered its vital role in digestive health, immune support, and inflammation reduction. This deeper understanding emphasizes the significance of maintaining a healthy gut microbiota, not just for alleviating specific gastrointestinal disorders but also for enhancing overall well-being. The evidence presented showcases L. reuteri’s ability to be a potent ally in promoting a balanced internal environment, highlighting its therapeutic potential across various health domains.
Inciting a broader appreciation for the complexities of our microbiome, this discussion underscores the importance of incorporating probiotic-rich foods and supplements, like those containing L. reuteri, into our daily routine. In doing so, we can harness the full spectrum of its health-promoting properties. As we continue to explore the symbiotic relationship between humans and their microbiota, let L. reuteri serve as a beacon guiding us toward optimal health through gut microbiome balance.